Molecular Pathogenesis of Pancreatic Cancer: Advances and Challenges

By  

Current Molecular Medicine, Vol. 7, Iss. 5, 2007-08 ,pp. : 504-521

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatic arterial infusion chemotherapy with gemcitabine and 5fluorouracil or oral S1 improves the prognosis of patients with postoperative liver metastases from pancreatic cancer

By                                                      

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 869-874

Spandidos Publications

Access to resources Recommend Favorite

Punctate midline myelotomy for intractable visceral pain caused by hepatobiliary or pancreatic cancer

By Hwang S.-L.   Lin C.-L.   Lieu A.-S.   Kuo T.-H.   Yu K.-L.   Ou-Yang F.   Wang S.-N.   Lee K.-T.   Howng S.-L.  

Journal of Pain and Symptom Management, Vol. 27, Iss. 1, 2004-01 ,pp. : 79-84

Elsevier

Access to resources Recommend Favorite

MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer

By  

Current Molecular Medicine, Vol. 16, Iss. 4, 2016-05 ,pp. : 404-411

Bentham Science Publishers

Access to resources Recommend Favorite

New Aspects of Regulatory Signaling Pathways and Novel Therapies in Pancreatic Cancer

By  

Current Molecular Medicine, Vol. 8, Iss. 1, 2008-01 ,pp. : 12-37

Bentham Science Publishers

Access to resources Recommend Favorite